Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric JunctionUlrich Ronellenfitsch, Johannes A. Vey, Jörg Kleeff et al.|JAMA Network Open|2024Cited by 13
10-year outcome of a randomized trial comparing neoadjuvant chemoradiotherapy and surgery with surgery alone for esophageal cancer (CROSS trial)Ben M. Eyck, Ate van der Gaast, Jan van Lanschot et al.|European Journal of Surgical Oncology|2021Cited by 2
Outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal squamous cell carcinoma in East Asia versus Western EuropeBen M. Eyck, Jan van Lanschot, Xing Gao et al.|European Journal of Surgical Oncology|2022Cited by 0
508. OUTCOME OF NEOADJUVANT CHEMORADIOTHERAPY PLUS SURGERY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA IN EAST ASIA VERSUS WESTERN EUROPEBen M. Eyck, Jan van Lanschot, Xing Gao et al.|Diseases of the Esophagus|2022Cited by 0
292. CHEMOTHERAPY AND CHEMORADIOTHERAPY FOR ADENOCARCINOMA OF THE OESOPHAGUS AND JUNCTION WITH OLIGOMETASTASES: RESULTS OF THE TNT-OES-1 TRIALCharlène Van Der Zijden, Sjoerd M. Lagarde, Ben M. Eyck et al.|Diseases of the Esophagus|2024Cited by 0